{"title":"Study of Levonorgestrel IUCD In Management Of Dysfunctional Uterine Bleeding","authors":"B. Thanmaye, B. Dhananjaya","doi":"10.46319/rjmahs.2019.v02i01.006","DOIUrl":null,"url":null,"abstract":"Introduction: Dysfunctional uterine bleeding (DUB) is a common problem in women which causes discomfort and decreases the quality of life. About 10-15% of women experience episodes of DUB at some point of time during the reproductive years of their lives. Annually 5-19% of women seek medical care. It accounts for more than 25% of all hysterectomies. Many treatment options are available. Objectives: To study efficacy of levonorgestrel IUCD in terms of blood loss, endometrial thickness, hemoglobin concentration and to evaluate side effects in DUB. Materials and methods: 40 women presenting with dysfunctional uterine bleeding were treated with levonorgestrel IUCD. The primary outcome in the study was reduction in menstrual loss measured using pictorial blood loss assessment chart (PBAC) score, increase in blood hemoglobin levels, reduction in thickness of","PeriodicalId":121001,"journal":{"name":"Research Journal of Medical and Allied Health Sciences","volume":"39 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research Journal of Medical and Allied Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46319/rjmahs.2019.v02i01.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Dysfunctional uterine bleeding (DUB) is a common problem in women which causes discomfort and decreases the quality of life. About 10-15% of women experience episodes of DUB at some point of time during the reproductive years of their lives. Annually 5-19% of women seek medical care. It accounts for more than 25% of all hysterectomies. Many treatment options are available. Objectives: To study efficacy of levonorgestrel IUCD in terms of blood loss, endometrial thickness, hemoglobin concentration and to evaluate side effects in DUB. Materials and methods: 40 women presenting with dysfunctional uterine bleeding were treated with levonorgestrel IUCD. The primary outcome in the study was reduction in menstrual loss measured using pictorial blood loss assessment chart (PBAC) score, increase in blood hemoglobin levels, reduction in thickness of